As of 2025-03-19, the Relative Valuation of Axsome Therapeutics Inc (AXSM) is (108.95) USD. This relative valuation is based on P/E multiples. With the latest stock price at 124.76 USD, the upside of Axsome Therapeutics Inc based on Relative Valuation is -187.3%.
The range of the Relative Valuation is (99.65) - (110.13) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 16.9x - 20.9x | 18.6x |
| Forward P/E multiples | 14.8x - 18.7x | 18.4x |
| Fair Price | (99.65) - (110.13) | (108.95) |
| Upside | -179.9% - -188.3% | -187.3% |
| Date | P/E |
| 2025-03-14 | -20.70 |
| 2025-03-13 | -20.66 |
| 2025-03-12 | -20.28 |
| 2025-03-11 | -20.29 |
| 2025-03-10 | -20.17 |
| 2025-03-07 | -20.74 |
| 2025-03-06 | -21.13 |
| 2025-03-05 | -21.24 |
| 2025-03-04 | -21.32 |
| 2025-03-03 | -21.59 |
| 2025-02-28 | -21.66 |
| 2025-02-27 | -21.46 |
| 2025-02-26 | -21.79 |
| 2025-02-25 | -21.58 |
| 2025-02-24 | -22.20 |
| 2025-02-21 | -23.39 |
| 2025-02-20 | -21.92 |
| 2025-02-19 | -21.56 |
| 2025-02-18 | -21.75 |
| 2025-02-14 | -22.27 |
| 2025-02-13 | -22.36 |
| 2025-02-12 | -22.34 |
| 2025-02-11 | -22.45 |
| 2025-02-10 | -21.58 |
| 2025-02-07 | -17.96 |
| 2025-02-06 | -18.59 |
| 2025-02-05 | -19.36 |
| 2025-02-04 | -19.17 |
| 2025-02-03 | -18.24 |
| 2025-01-31 | -18.08 |
| 2025-01-30 | -18.48 |
| 2025-01-29 | -17.85 |
| 2025-01-28 | -17.40 |
| 2025-01-27 | -17.44 |
| 2025-01-24 | -17.51 |
| 2025-01-23 | -17.64 |
| 2025-01-22 | -17.37 |
| 2025-01-21 | -16.33 |
| 2025-01-17 | -15.61 |
| 2025-01-16 | -15.91 |
| 2025-01-15 | -15.92 |
| 2025-01-14 | -14.37 |
| 2025-01-13 | -15.16 |
| 2025-01-10 | -13.59 |
| 2025-01-08 | -14.02 |
| 2025-01-07 | -14.23 |
| 2025-01-06 | -14.46 |
| 2025-01-03 | -14.68 |
| 2025-01-02 | -14.83 |
| 2024-12-31 | -14.37 |